Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

Alteration of the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin signaling pathway is key for the growth and survival of several cancers, including breast cancer. In addition, dysregulation of PI3K signaling may contribute to resistance to several anticancer agents. PI3K inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Criscitiello, Carmen, Viale, Giulia, Curigliano, Giuseppe, Goldhirsch, Aron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796458/
https://www.ncbi.nlm.nih.gov/pubmed/29430197
http://dx.doi.org/10.2147/BCTT.S134641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796458/
https://www.ncbi.nlm.nih.gov/pubmed/29430197
http://dx.doi.org/10.2147/BCTT.S134641

Ejemplares similares